Salvina Therapeutics Overview

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

Salvina Therapeutics General Information

Description

Operator of a biotech firm intended to perform research on antibodies. The company develops new therapies to break efficacy ceilings in inflammatory and autoimmune diseases, providing medical companies with products to treat diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hegenheimermattweg 167A
  • 4123 Allschwil
  • Switzerland
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Hegenheimermattweg 167A
  • 4123 Allschwil
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Salvina Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Jul-2024 Completed Startup
1. Accelerator/Incubator 10-Jun-2023 Completed Startup
To view Salvina Therapeutics’s complete valuation and funding history, request access »

Salvina Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Salvina Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioMedPartners Venture Capital Minority
CARMA FUND Management Venture Capital Minority
BaseLaunch Accelerator/Incubator
To view Salvina Therapeutics’s complete investors history, request access »

Salvina Therapeutics FAQs

  • Where is Salvina Therapeutics headquartered?

    Salvina Therapeutics is headquartered in Allschwil, Switzerland.

  • What is the size of Salvina Therapeutics?

    Salvina Therapeutics has 5 total employees.

  • What industry is Salvina Therapeutics in?

    Salvina Therapeutics’s primary industry is Biotechnology.

  • Is Salvina Therapeutics a private or public company?

    Salvina Therapeutics is a Private company.

  • What is Salvina Therapeutics’s current revenue?

    The current revenue for Salvina Therapeutics is .

  • Who are Salvina Therapeutics’s investors?

    BioMedPartners, CARMA FUND Management, and BaseLaunch have invested in Salvina Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process